To investigate the contribution of FGL1 to liver diseases, we compared wild‐type mice to mice with hepatocyte‐specific deletion of Fgl1 subjected to a steatosis or HCC experimental protocol. This evidence concerns the gene FGL1 and hepatocellular carcinoma.